Nova Clinic is glad to offer their patients a genetic screening for fetal chromosomal mutations through the analysis of the mother’s blood sample with the help of next-generation sequencing (NGS) technique.
Non-invasive genetic test helps detect most wide-spread chromosomal pathologies:
A patient receives the geneticist’s medical conclusion as well as the results of the test.
There is no contact with an embryo’s membrane, which, otherwise, may cause miscarriages or other complications. A venous blood sample collected from a woman is quite enough to perform the test. All these are safe both for the mother and the fetus.
The non-invasive test uses fetal DNA, which, unlike an ultrasound and a biochemical screening, is a direct diagnostic technique with accuracy up to 99,9%. It should be also noted that the percentage of inaccurate (false-positive) results is inferior than 0,1% .
The test can be recommended to all pregnant women who want to obtain additional information on their babies’ health condition. However, the test is usually recommended to women running a high risk of having a baby with chromosomal mutations: